Group One Trading’s Gyre Therapeutics GYRE Stock Holding History

Group One Trading’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-87,800	Closed	-$1.06M	–	7890
2024 Q4	$1.06M	Hold	87,800	–	–	﹤0.01%	2526
2024 Q3	$1.1M	Buy	87,800 +500	+0.6%	+$6.45K	﹤0.01%	2215
2024 Q2	$1.04M	Hold	87,300	–	–	﹤0.01%	1953
2024 Q1	$1.53M	Buy	87,300 +13,400	+18%	+$241K	0.01%	1717
2023 Q4	$1.9M	Buy	73,900 +69,027	+1,417%	+$979K	0.01%	1917
2023 Q3	$35.3K	Buy	4,873 +553	+13%	+$3.7K	﹤0.01%	5414
2023 Q2	$22.8K	Sell	4,320 -380	-8%	-$1.36K	﹤0.01%	5901
2023 Q1	$14.6K	Sell	4,700 -167	-3%	-$635	﹤0.01%	5726
2022 Q4	$19.3K	Sell	4,867 -260,640	-98%	-$1.06M	﹤0.01%	5623
2022 Q3	$1M	Sell	265,507 -157,493	-37%	-$2M	﹤0.01%	2581
2022 Q2	$5.65M	Buy	423,000 +420,840	+19,483%	+$2.8M	0.01%	1207
2022 Q1	$11K	Sell	2,160 -20,413	-90%	-$101K	﹤0.01%	7115
2021 Q4	$155K	Sell	22,573 -37,574	-62%	-$642K	﹤0.01%	5347
2021 Q3	$1.85M	Buy	60,147 +52,760	+714%	+$1.74M	﹤0.01%	2738
2021 Q2	$240K	Sell	7,387 -25,493	-78%	-$875K	﹤0.01%	5027
2021 Q1	$1.24M	Buy	32,880 +30,253	+1,152%	+$1.38M	﹤0.01%	2976
2020 Q4	$124K	Sell	2,627 -4,533	-63%	-$196K	﹤0.01%	4405
2020 Q3	$231K	Buy	7,160 +5,867	+454%	+$230K	﹤0.01%	3538
2020 Q2	$57K	Buy	+1,293	New	+$60.7K	﹤0.01%	4270
2019 Q4	–	Sell	-400	Closed	-$15K	–	5295
2019 Q3	$15K	Buy	+400	New	+$21.6K	﹤0.01%	4461
2019 Q1	–	Sell	-800	Closed	-$47K	–	5018
2018 Q4	$47K	Sell	800 -493	-38%	-$36.4K	﹤0.01%	3593
2018 Q3	$105K	Buy	1,293 +573	+80%	+$45.4K	﹤0.01%	3499
2018 Q2	$63K	Buy	720 +693	+2,567%	+$122K	﹤0.01%	3827
2018 Q1	$5K	Buy	+27	New	+$5.04K	﹤0.01%	4499
2017 Q2	–	Sell	-17,360	Closed	-$1.23M	–	4873
2017 Q1	$1.23M	Buy	+17,360	New	+$1.01M	0.01%	1192
2016 Q2	–	Sell	-3	Closed	-$1K	–	4735
2016 Q1	$1K	Hold	3	–	–	﹤0.01%	4439
2015 Q4	$1K	Sell	3 -47	-94%	-$18.5K	﹤0.01%	4609
2015 Q3	$26K	Buy	50 +25	+100%	+$38.1K	﹤0.01%	3911
2015 Q2	$55K	Sell	25 -50	-67%	-$100K	﹤0.01%	3483
2015 Q1	$175K	Buy	75 +54	+257%	+$112K	﹤0.01%	2481
2014 Q4	$43K	Sell	21 -27	-56%	-$52K	﹤0.01%	3473
2014 Q3	$95K	Sell	48 -65	-58%	-$161K	﹤0.01%	3041
2014 Q2	$400K	Buy	113 +31	+38%	+$101K	0.01%	1827
2014 Q1	$307K	Buy	82 +37	+82%	+$137K	0.01%	2086
2013 Q4	$147K	Buy	45 +17	+61%	+$67K	﹤0.01%	2699
2013 Q3	$117K	Buy	28 +3	+12%	+$12.1K	﹤0.01%	2877
2013 Q2	$85K	Buy	+25	New	+$95.1K	﹤0.01%	2960

Other funds holding GYRE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's GYRE Position: Q2 2025 in Review

Group One Trading sold out of Gyre Therapeutics (GYRE) in Q2 2025, closing a stake of 485 shares — an estimated $3.74K sold.

Group One Trading first reported a position in GYRE in Q2 2013 and held it in 24 quarters. The position peaked at $247K in Q2 2014. 48 funds tracked by Wall St. Rank hold GYRE as of Q2 2025.

Group One Trading reported no remaining Gyre Therapeutics position as of Q2 2025 after selling out during the quarter.
Group One Trading sold 485 Gyre Therapeutics shares in Q2 2025, an estimated $3.74K.
Group One Trading first reported a position in Gyre Therapeutics in Q2 2013 and held it in 24 quarters.
Group One Trading's Gyre Therapeutics position peaked at $247K in Q2 2014.
48 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.